Working towards sustainable hospital management: constraints and opportunities
Jean-Rémy Bitaud, Directeur du Projet Management Durable de l’AP-HP, France

Sustainable development in the purchasing of proprietary medicines
Nicole Poisson, Pharmacien praticien hospitalier, UF évaluation achats des médicaments (UF EAM) - AGEPS AP Paris

• Obligations under the public call for tender code and feasibility in drug procurement
• The aspects of sustainable development chosen for drug procurement:

Drug Delivery Devices - making disposable more sustainable
Daniel Lintell, Medical manager, DCA Design, UK
Robert Veasey, Medical manager, DCA Design, UK

Patient safety, usability, compliance and counterfeiting risks have all helped to drive a trend away from reusable drug delivery devices, towards disposable products. The conventional view is that this trend is significantly at odds with environmental sustainability, but how can we assess the evidence?

This presentation will examine the factors that influence the ‘environmental [To read more]

Environmentally Friendly Solutions for Solid Oral Dose Packaging

Roy Christopherson, Innovation Director, AMCOR Flexibles, UK

With the recent high level of concern regarding the future use of raw materials, it is time to consider alternative systems that reduce the amount of material required to pack sensitive pharmaceutical products, and hence reduce the environmental impact of the packaging. AMCOR Flexibles Healthcare, a company listed in the Dow Jones Sustainability World Index, has a co-ordinated approach to sustainability driven over the last number of years [To read more]

Sustainability in Pharmaceutical Packaging made measurable
Dr. Manfred Zurkirch, CEO Dividella AG, Switzerland

This presentation will compare the environmental sustainability of different secondary parenteral packaging solutions. The investigation is based on the complete Life-Cycle Assessment concept.

• Definition of environmental sustainability and the impact on the pharmaceutical industry
• Analysis of the sustainability of different pack styles through a “Life-Cycle-Assessment”

• Evaluation of the data and suggestions for improvement [To read more]

Innovative films / foil solutions – Technical requirements vs. Regulatory Affairs from a converter perspective

Stefan Frischmann, Head of Product Development for the Division Pharma & Film, Constantia Hueck-Folien, Germany
Dr. Dirk Kaczmarek, Head of R&D and sustainability Manager for the Division Pharma & Film, Constantia Hueck-Folien, Germany

The paper will speak about innovative films / foil solutions for a broad range of products and how the different technical requirements (easy opening; controlled access) can be integrated into the material with the fulfillment of the Regulatory Affairs. Furthermore, the view of Constantia Flexibles in the field of sustainability will be shown.

How can technology help to effectively combat counterfeits in the pharmaceutical area?

Jean-Marc Bobée, Directeur de la Stratégie Anti-Contrefaçon industrielle, Sanofi-Aventis, France

After briefly recalling the development, causes and consequences of drug counterfeiting in the world, the author will describe and discuss the three key principles of a technological strategy to fight counterfeit: guarantee the integrity of secondary packaging throughout the distribution chain, protect products at risk through authentication devices and improve traceability by using harmonised coding and identification, [To read more]

How to comply in 350 days?
Jean-Luc LASNE, Directeur, Laetus, France

The 31/12/2010 deadline laid down by AFSSAPS for Datamatrix marking of the CIP13 code on drug packaging is drawing near. Businesses that have not yet invested can now choose from among the standard solutions offered by numerous suppliers. We shall be listing these various solutions and then describing a machine in which the control software, usually considered an ancillary function, plays a key role in guaranteeing [To read more]

Low-cost effective invisible anti-counterfeiting solutions to protect primary and secondary packaging and labels, as well as the tablet itself

Roland Meylan, Corporate Communications Manager, AlpVision SA, Switzerland

The increase in the complexity of the pharmaceutical supply chain in today’s global economy makes certification of every single supply source a nightmare. This is certainly a key factor in the rapid increase of counterfeiting attacks, including in countries where the supply chains are well established and trustworthy. Protection of pharmaceutical products against counterfeiting is now possible at the tablet level itself, [To read more]

Authenticity, Tamper Evidence and Tracing of Genuine Pharmaceutical Products
Thomas Voelcker, Marketing & Sales Director, Schreiner ProSecure, Germany

The alarming increases of counterfeits imported into the European market have forced the EU commission to push for a standard Europe-wide policy and to work on respective directives. Brussels is planning a fundamental amendment of Directive 2001/83/EC. The proposals call for future mandatory application of a security seal and combined security features to every pharmaceutical pack sold in Europe. [To read more]

Unitary authentication of pharmaceutical packagings
Yann Boutant, Directeur Général, Signoptic technologies SAS, France

SIGNOPTICTM Technology uses natural properties of materials (« biometry materials ») in order to generate a unitary authenticator from virtually any document or manufactured good. Applied in the Pharmaceutical packaging environment, it helps to protect organizations from counterfeiting, diversion or liabilities issues. Suitable with EFPIA initiative in term of track and trace of pharmaceutical packagings, [To read more]

Chemical tag : a simple way of securing a traceability system
Florent Denjean, Security and Brand Protection Market Manager, Arjowiggins Security, France

• Secumatrix : a chemical marker to combine authentication and the identification of traceability systems.
A chemical tag - invisible and undetectable, and therefore impossible to forge - is a solution that protects the product traceability code.

AWS simplifies the securisation process and [To read more]

Profile of first-choice injectables used by the ICRC

Addressing the needs of high demanding biopharmaceuticals using an innovative Ready-to-Use COP syringe system
Mrs. Claudia Petersen, Director of Business Development, Gerresheimer Bünde GmbH, Germany

• New ultra clean elastomer formulation to improve drug product compatibility
• Optimal system functionality by improved siliconization process
• Cosmetic and dimensional quality aspects

Embracing system approaches in the selection of the best rubber stopper for sensitive drugs
Nicolas Morais, Product Manager for Prefillable Syringe Systems, BD Medical - Pharmaceutical Systems, France

It is well known that special care should be taken when choosing a rubber stopper for a sensitive drug, like a biotech drug. Chemical interactions with rubber can be of highest importance.

In the scope of this presentation, we will demonstrate that, after insurance of supply, one of the first requirements that a stopper should [To read more]

Qualification of MD packaging suitable for the main methods of sterilisation
Caroline Soufflet, Responsable développement STERRAD, Advance Sterilization Product, France
Cyrille Maréchal, Directeur Général, Top Clean Injection, France

• Technical adaptation of our packaging offering to the various sterilisation methods :
   - The different materials : APET, PETG, PC, PE...
   - The different methods of sterilisation : ETO, Plasma, Steam, Radiation
   - Focus on plasma sterilisation
• Packaging qualification: [To read more]

Implementation of Needle-Stick Safety Device with Injectable Drugs - Experiences and “Lessons learned” from more than 20 drug launches
Fred Field, VP of Research & Product Development, Safety Syringes, UK

Questions this session will address:
• Why needle-stick safety is of increasing importance to:
  - health care professionals
  - pharma / biopharma companies (legislation changes, competitive environment)

• What safety device options exist and how are they different? [To read more]

A tungsten-free innovative staked needle syringe system to reduce pain and improve drug stability
Carmen Heiter, Product Manager Syringes, SCHOTT forma Vitrum, Switzerland

• Innovative staked needle syringe system
• No contact of drug to needle, luer channel, and needle glue during shelf life
• Reduced pain by unused, very fine needle
• Tamper evident / anti-counterfeiting
• High flexibility in configuration [To read more]

Needle-Free Diluent kits for IV drugs, a way to protect medical staff and patients.
Chistophe Sanfilippo, Sales Manager, Bioluz, France

Alerts are made by authorities world-wide on needle-stick injury prevention during reconstitution of IV drugs. Technoflex brings the concept of a complete needle-free diluent kit to avoid needle stick injuries or add-mixture errors: the correct drug with the correct diluent reconstituted in a safe way.

This latest generation of transfer device is already [To read more]

Logistic Systems for the Supply of Primary Packaging Materials Made of Tubular Glass
Alfred Breunig, Director Technical Customer Support, MGlas AG (abbreviated: MG), Germany

While the technical development of primary packaging materials made of tubular glass (syringes, vials, ampoules) is meanwhile far advanced, there is still potential for improvement in the logistic sequences for the supply. The pharmaceutical industry is meanwhile also introducing more just-in-time oriented logistics systems, which are already common in other industries. Such logistics systems can only be implemented [To read more]

Veterinary drugs : specificities for the user and the prescriber
Renaud Tissier, DVM, PhD, Maître de Conférences en Pharmacie-Toxicologie, Ecole Nationale Vétérinaire d’Alfort et unité INSERM U955, France

Like drugs for people, veterinary drugs must meet quality, efficacy and safety standards. However, veterinary drugs do have certain specificities. First, oral administration is not always simple, as cat and dog owners often find it difficult to get their pets to swallow oral forms. Liquid forms administered through the skin [To read more]

Packaging and veterinary drugs: constraints and opportunities for the pharmaceutical industry
Bertrand Havrileck, Director of pharmaceutical R&D, Laboratoires VIRBAC, France

Packaging is an essential part of the drug. A finished product comprises of three main entities: the active ingredients, the excipients and the packaging. All three are closely interlinked and interdependent. Like excipients, packaging can play a central role as a vector for the active ingredients, and each influences the other. [To read more]

Case study of a unit dose package for a solvent based veterinary product, including an active packaging component.
Michiel Van der Berg, Director. Global Pharmaceutical Packaging Development, TEKNIPLEX, Belgium

A novel desiccant plastic strip, based on a molecular sieve, is included in the package of a solvent based liquid for a veterinary product. Unitdose packaging blister packaging is the preferred delivery form for such type of treatment and prevention of infestations by fleas and ticks on companion animals. The solvent based liquid poses particular challenges on the plastic blister pack in terms of barrier to moisture and [To read more]